EPGNF

Epigenomics AG

 
Ordinary Shares International Reporting
OTCQX International OTCQX Advisor: BNY Mellon
Verified Company Profile 8/10/2017
Contact Info
  • GeneststraBe 5
  • Berlin D-10829
  • Germany

Business Description


 
Financial Reporting/Disclosure
Reporting Status International Reporting: Frankfurt Stock Exchange
Audited Financials Audited
Latest Report Jun 30, 2017 Semi-Annual Report
CIK 0001580128
Fiscal Year End 12/31
OTC Marketplace OTCQX International
Profile Data
SIC - Industry Classification 2835 - Diagnostic substances
Incorporated In: Germany
Year of Inc. 1998
Employees 39 a/o Dec 30, 2015
Company Officers/Contacts
Heino von Prondzynski Chairman of the Supervisory Board
Gregory Hamilton CEO
Dr. Uwe Staub COO
Peter Vogt VP, Corp. Comm., IR
Caroline Bergman Other
Company Directors
Ann Clare Kessler, Ph.D.
Prof. Gunther Reiter
Company Notes
  • Sponsored for OTCQX by BNY Mellon on 01/10/2014
Service Providers
OTCQX Advisor
BNY Mellon
101 Barclay Street
22nd Floor
New York, NY, 10286
USA

Accounting/Auditing Firm Legal Counsel
Hengeler Mueller
Behrenstrasse 42
Berlin, 10117
Germany

Behrenstrass'e
Investor Relations Firm
Not Available
EPGNF Security Details Other Company Securities
Share Structure
Market Value1 $128,454,219 a/o Oct 20, 2017
Authorized Shares 22,735,260 a/o Dec 31, 2016
Outstanding Shares 22,735,260 a/o Dec 31, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value Not Available
Transfer Agent(s)
Shareholders
Shareholders of Record Not Available
Non US Stock Exchange Listing
ECX - Frankfurt Stock Exchange - Qualified
Short Selling Data
Short Interest 73,486 (-25.85%)
Sep 29, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security